MMP inhibitors

   
   

Novel compounds according to formula I ##STR1## n is 0, 1, 2 or 3; X represents hydroxamic acid (CONHOH), carboxylic acid, phosphonic acid, acetylthiomethyl group or a mercaptomethyl group; R2, R10 and R11 independently represent hydrogen or (C.sub.1-8)alkyl, (C.sub.2-6)alkenyl, (C.sub.3-8)cycloalkyl, aryl(C.sub.0-6)alkyl or heteroaryl(C.sub.0-6)alkyl, all of which may optionally be substituted; R3 and R4 independently represent hydrogen, hydroxy or alkoxy; provided that if A, A', Z and R5 are all bonds, and s and t are both 0 (zero), then R6 is different from hydrogen, and that at least one of R3, R4, R10 and R11 is different from hydrogen; or a salt, hydrate or solvate thereof; pharmaceutical compositions comprising said compound; therapeutical methods comprising administering said compounds; and the use of said compounds in the manufacture of medicaments.

 
Web www.patentalert.com

< Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof

< MCH antagonists and their use in the treatment of obesity

> Pt-Ru-M1-M2 quaternary metal catalyst based on Pt-Ru for direct methanol fuel cell

> Antibody kits for selectively inhibiting VEGF

~ 00129